William Blair & Company’s Dynavax Technologies DVAX Stock Holding History

William Blair & Company’s Portfolio DVAX Stock Details DVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-6,000	Closed	-$74K	–	1691
2018 Q3	$74K	Buy	6,000 +800	+15%	+$10.8K	﹤0.01%	1415
2018 Q2	$79K	Buy	5,200 +1,200	+30%	+$20.7K	﹤0.01%	1363
2018 Q1	$79K	Sell	4,000 -1,400	-26%	-$24.2K	﹤0.01%	1293
2017 Q4	$101K	Buy	+5,400	New	+$108K	﹤0.01%	1313
2017 Q3	–	Sell	-4,400	Closed	-$42K	–	1403
2017 Q2	$42K	Buy	+4,400	New	+$28.6K	﹤0.01%	1483
2016 Q4	–	Sell	-28,400	Closed	-$298K	–	1415
2016 Q3	$298K	Buy	+28,400	New	+$408K	﹤0.01%	1015
2016 Q2	–	Sell	-400	Closed	-$7K	–	1242
2016 Q1	$7K	Buy	+400	New	+$8.08K	﹤0.01%	1174
2015 Q2	–	Sell	-3,000	Closed	-$67K	–	2206
2015 Q1	$67K	Hold	3,000	–	–	﹤0.01%	2071
2014 Q4	$50K	Buy	+3,000	New	+$45.7K	﹤0.01%	2051

Other funds holding DVAX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

William Blair & Company's DVAX Position: Q1 2026 in Review

William Blair & Company sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 1,781,442 shares — an estimated $27.4M sold.

William Blair & Company first reported a position in DVAX in Q2 2013 and held it in 50 quarters. The position peaked at $43.2M in Q3 2021. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

William Blair & Company reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
William Blair & Company sold 1,781,442 Dynavax Technologies shares in Q1 2026, an estimated $27.4M.
William Blair & Company first reported a position in Dynavax Technologies in Q2 2013 and held it in 50 quarters.
William Blair & Company's Dynavax Technologies position peaked at $43.2M in Q3 2021.
1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on William Blair & Company's 13F filing for Q1 2026, filed 8 May 2026.